Michael A. Postow - Publications, H-index & Citations

Michael A. Postow

weill cornell medical college

88H指数

657论文数

6.5W被引数

收录论文 128

发表时间

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years 原发性黑色素瘤假阴性诊断患者的生命损失年数。一项涉及9063例患者、为期28年的德国中央恶性黑色素瘤登记研究的回顾性研究

Nature Communications

IF15.7

2026-07-02

OAAI

Claus Garbe; Ulrike Keim; Teresa Amaral; Paolo A. Ascierto; Jürgen Bauer; Reinhard Dummer; Alexander M. M. Eggermont; Thomas K. Eigentler; Lukas Flatz; Stephan Forchhammer; Andrea Forschner; Sara Gandini; Jeffrey E. Gershenwald; Axel Hauschild; Christoph Hoeller; John M. Kirkwood; Celeste Lebbe; Georgina V. Long; Paul Lorigan; Jason J. Luke; Friedegund Meier; Gisela Metzler; Paul Nathan; Michael A. Postow; Caroline Robert; Martin Röcken; Dirk Schadendorf; Benjamin Weide; David Whiteman; Ulrike Leiter; Peter Martus

Thinking beyond immunotherapy: implementing a multimodal care plan to facilitate extended survival in stage IV melanoma 超越免疫疗法：实施多模式护理计划以促进IV期黑色素瘤的长期生存

Melanoma Research

IF0

2026-02-01

PREAI

Sreeram, Aravind; Postow, Michael A.; Moy, Andrea P.; Ariyan, Charlotte E.; Bello, Danielle M.

Pretreatment naive Tcells are associated with severe irAE following PD-1/CTLA-4 checkpoint blockade for melanoma 治疗前naïve T细胞与黑色素瘤PD-1/CTLA4检查点阻断后严重irAE相关

JCI Insight

IF6.1

2026-01-23

PREAI

Marks, Kathryne E.; Horisberger, Alice; Elahee, Mehreen; Adejoorin, Ifeoluwakiisi A.; Ghosh, Nilasha; Postow, Michael; Donlin, Laura; Bass, Anne R.; Rao, Deepak A.

Validation of the Functional Assessment of Cancer Therapy - Immune Checkpoint Modulator 17-Item Symptom Index (FACT-ICM-17) to facilitate implementation in research and clinical care 功能性癌症治疗评估-免疫检查点调节剂17项症状指数（FACT-ICM-17）的验证，以促进其在研究和临床护理中的应用

CANCER

IF5.1

2025-10-15

OAAI

Gudenkauf, Lisa M.; Tometich, Danielle B.; Hoogland, Aasha I.; Li, Xiaoyin; Kirtane, Kedar; Small, Brent J.; Barata, Anna; Gonzalez, Brian D.; Jacobs, K. D.; Chung, Christine H.; Shafique, Michael R.; Gray, Jhanelle; Khushalani, Nikhil I.; Postow, Michael A.; Cella, David; Webster, Kimberly A.; Dicker, Adam P.; Jim, Heather S. L.

Programmed death ligand-1 PET imaging in patients with melanoma: a pilot study 程序性死亡配体-1 PET成像在黑色素瘤患者中的应用：一项初步研究

MELANOMA RESEARCH

IF0

2025-10-01

PREAI

Pandit-Taskar, Neeta; Mauguen, Audrey; Frosina, Denise; Jungbluth, Achim; Busam, Klaus J.; Lyashchenko, Serge; Schwartz, Jazmin; Momtaz, Parisa; Warner, Allison Betof; Smithy, James W.; Shoushtari, Alexander N.; Chapman, Paul B.; Callahan, Margaret K.; Postow, Michael A.

Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer Fc优化的CD40激动性抗体在转移性癌症中诱导三级淋巴样结构形成并引发系统性抗肿瘤免疫。

Cancer Cell

IF44.5

2025-08-14

OAAI

Juan C. Osorio; David A. Knorr; Polina Weitzenfeld; Lucas Blanchard; Ning Yao; Maria Baez; Carlo Sevilla; Meghan DiLillo; Jahan Rahman; Ved P. Sharma; Jacqueline Bromberg; Michael A. Postow; Charlotte Ariyan; Mark E. Robson; Jeffrey V. Ravetch

Sarcoid-like reactions in patients treated with checkpoint inhibitors for advanced solid tumors 接受免疫检查点抑制剂治疗晚期实体瘤患者的类肉瘤样反应

ONCOLOGIST

IF4.2

2025-05-11

OAAI

Nykaza, Ian; Murciano-Goroff, Yonina R.; Desilets, Antoine; Harada, Guilherme; Postow, Michael A.; Callahan, Margaret K.; Lee, Chung-Han; Rudin, Charles M.; Kelsen, David Paul; Stadler, Zsofia K.; Wibmer, Andreas G.; Hechtman, Jaclyn F.; Drilon, Alexander; Friedman, Claire F.

Top advances of the year: Neoadjuvant immunotherapy in melanoma 年度最佳进展: 黑色素瘤的新辅助免疫疗法

CANCER

IF5.1

2025-04-30

PREAI

Chen, Monica F.; Postow, Michael A.

Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling 全基因组规模的纠错型流式测序及其在循环游离DNA分析中的应用

NATURE METHODS

IF32.1

2025-04-11

PREAI

Cheng, Alexandre Pellan; Widman, Adam J.; Arora, Anushri; Rusinek, Itai; Sossin, Aaron; Rajagopalan, Srinivas; Midler, Nicholas; Hooper, William F.; Murray, Rebecca M.; Halmos, Daniel; Langanay, Theophile; Chu, Hoyin; Inghirami, Giorgio; Potenski, Catherine; Germer, Soren; Marton, Melissa; Manaa, Dina; Helland, Adrienne; Furatero, Rob; Mcclintock, Jaime; Winterkorn, Lara; Steinsnyder, Zoe; Wang, Yohyoh; Alimohamed, Asrar I.; Malbari, Murtaza S.; Saxena, Ashish; Callahan, Margaret K.; Frederick, Dennie T.; Spain, Lavinia; Sigouros, Michael; Manohar, Jyothi; King, Abigail; Wilkes, David; Otilano, John; Elemento, Olivier; Mosquera, Juan Miguel; Jaimovich, Ariel; Lipson, Doron; Turajlic, Samra; Zody, Michael C.; Altorki, Nasser K.; Wolchok, Jedd D.; Postow, Michael A.; Robine, Nicolas; Faltas, Bishoy M.; Boland, Genevieve; Landau, Dan A.

Quantitatively defined stromal B cell aggregates are associated with response to checkpoint inhibitors in unresectable melanoma 量化定义的基质B细胞聚集物与不可切除黑色素瘤对检查点抑制剂的应答相关

CELL REPORTS

IF6.9

2025-04-01

OAAI

Smithy, James W.; Peng, Xiyu; Ehrich, Fiona D.; Moy, Andrea P.; Yosofvand, Mohammad; Maher, Colleen; Aleynick, Nathaniel; Vanguri, Rami; Zhuang, Mingqiang; Lee, Jasme; Bleile, MaryLena; Li, Yanyun; Postow, Michael A.; Panageas, Katherine S.; Hollmann, Travis J.; Callahan, Margaret K.; Shen, Ronglai

Artificial Intelligence for Drug Discovery: An Update and Future Prospects 人工智能在药物发现中的应用：最新进展与未来展望

SEMINARS IN NUCLEAR MEDICINE

IF5.9

2025-02-01

PREAI

Harrison J. Howell; Jeremy P. McGale; Aurélie Choucair; Dorsa Shirini; Nicolas Aide; Michael A. Postow; Lucy Wang; Mickael Tordjman; Egesta Lopci; Augustin Lecler; Stéphane Champiat; Delphine L. Chen; Désirée Deandreis; Laurent Dercle

Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti-PD-1 Therapy 伊匹木单抗和纳武利尤单抗在PD-1抑制剂治疗后进展的黑色素瘤脑转移中的颅内疗效

JAMA ONCOLOGY

IF20.1

2025-01-30

PREAI

Lochrin, Sarah E.; Kalvin, Hannah L.; Smithy, James W.; Chen, Monica F.; Momtaz, Parisa; Shoushtari, Alexander N.; Panageas, Katherine S.; Postow, Michael A.

Long-term outcomes among patients who respond within the first year to nivolumab plus ipilimumab or nivolumab monotherapy: A pooled analysis in 935 patients

EUROPEAN JOURNAL OF CANCER

IF7.1

2025-01-01

OAAI

Robert, C.; Long, G. V.; Larkin, J.; Wolchok, J. D.; Hassel, J. C.; Schadendorf, D.; Hodi, F. S.; Lebbe, C.; Grob, J. -j.; Hyngstrom, J. R.; Wagstaff, J.; Chesney, J.; Butler, M. O.; Bechter, O.; Marquez-Rodas, I.; Pavlick, A. C.; Durani, P.; Benito, M. Pe; Wang, P.; Postow, M. A.; Ascierto, P. A.

Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis

JOURNAL OF EXPERIMENTAL MEDICINE

IF10.6

2024-12-12

OAAI

Shang, Joan; Del Valle, Diane Marie; Britton, Graham J.; Mead, K. R.; Rajpal, Urvija; Chen-Liaw, Alice; Mogno, Ilaria; Li, Zhihua; Menon, Rajita; Gonzalez-Kozlova, Edgar; Elkrief, Arielle; Peled, Jonathan U.; Gonsalves, Tina Ruth; Shah, Neil J.; Postow, Michael; Colombel, Jean-Frederic; Gnjatic, Sacha; Faleck, David M.; Faith, Jeremiah J.

Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab 使用dabrafenib，trametinib和nivolumab治疗后的软脑膜黑色素瘤患者的持久完全缓解

PIGMENT CELL & MELANOMA RESEARCH

IF2.6

2024-07-03

PREAI

Lochrin, Sarah E.; Buonocore, Darren J.; Young, Robert J.; Kaley, Thomas J.; Postow, Michael A.; Wolchok, Jedd D.; Shoushtari, Alexander N.; Momtaz, Parisa; Warner, Allison S. Betof; Callahan, Margaret K.

Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment 使用机器学习引导的信号富集技术对基于血浆的肿瘤负荷进行超灵敏监测

NATURE MEDICINE

IF50

2024-06-14

OAAI

Widman, Adam J.; Shah, Minita; Frydendahl, Amanda; Halmos, Daniel; Khamnei, Cole C.; Ogaard, Nadia; Rajagopalan, Srinivas; Arora, Anushri; Deshpande, Aditya; Hooper, William F.; Quentin, Jean; Bass, Jake; Zhang, Mingxuan; Langanay, Theophile; Andersen, Laura; Steinsnyder, Zoe; Liao, Will; Rasmussen, Mads Heilskov; Henriksen, Tenna Vesterman; Jensen, Sarah ostrup; Nors, Jesper; Therkildsen, Christina; Sotelo, Jesus; Brand, Ryan; Schiffman, Joshua S.; Shah, Ronak H.; Cheng, Alexandre Pellan; Maher, Colleen; Spain, Lavinia; Krause, Kate; Frederick, Dennie T.; den Brok, Wendie; Lohrisch, Caroline; Shenkier, Tamara; Simmons, Christine; Villa, Diego; Mungall, Andrew J.; Moore, Richard; Zaikova, Elena; Cerda, Viviana; Kong, Esther; Lai, Daniel; Malbari, Murtaza S.; Marton, Melissa; Manaa, Dina; Winterkorn, Lara; Gelmon, Karen; Callahan, Margaret K.; Boland, Genevieve; Potenski, Catherine; Wolchok, Jedd D.; Saxena, Ashish; Turajlic, Samra; Imielinski, Marcin; Berger, Michael F.; Aparicio, Sam; Altorki, Nasser K.; Postow, Michael A.; Robine, Nicolas; Andersen, Claus Lindbjerg; Landau, Dan A.

Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-01-29

OAAI

Sala, Isabella; Pagan, Eleonora; Pala, Laura; Oriecuia, Chiara; Musca, Marco; Specchia, Claudia; De Pas, Tommaso; Cortes, Javier; Giaccone, Giuseppe; Postow, Michael; Gelber, Richard D.; Bagnardi, Vincenzo; Conforti, Fabio

Recent Advances in the Field of Artificial Intelligence for Precision Medicine in Patients with a Diagnosis of Metastatic Cutaneous Melanoma 诊断为转移性皮肤黑色素瘤的患者的精准医学人工智能领域的最新进展

DIAGNOSTICS

IF3.3

2023-11-20

OAAI

Higgins, Hayley; Nakhla, Abanoub; Lotfalla, Andrew; Khalil, David; Doshi, Parth; Thakkar, Vandan; Shirini, Dorsa; Bebawy, Maria; Ammari, Samy; Lopci, Egesta; Schwartz, Lawrence H.; Postow, Michael; Dercle, Laurent

Comparison of intracranial (IC) response assessment criteria in patients (pts) with melanoma brain metastases (MBM) treated with combination nivolumab (NIVO) plus ipilimumab (IPI) in CheckMate 204

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Huang, R.; Youssef, G.; Nelson, T.; Wen, P.; Forsyth, P.; Hodi, F. S.; Margolin, K. A.; Algazi, A. P.; Hamid, O.; Lao, C. D.; Ernstoff, M. S.; Moschos, S. J.; Atkins, M. B.; Postow, M.; Reardon, D. A.; Grootendorst, D. J.; Askelson, M.; Ritchings, C.; Tawbi, H. A.

Relapse free survival (RFS) at 3 years by pathological (path) response to neoadjuvant systemic treatment (NST) in patients (pts) with surgically resectable, high-risk melanoma

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Burton, E.; Milton, D.; Simpson, L.; Tetzlaff, M.; Glitza, I. C.; Ross, M. I.; Gershenwald, J. E.; Mcquade, J.; Wong, M.; Patel, S.; Diab, A.; Postow, M.; Ariyan, C. E.; Lee, J.; Fisher, S.; Prieto, V.; Davies, M.; Tawbi, H. A.; Wargo, J.; Amaria, R.

研究方向